(S1 (S (S (NP (NP (NNS PBMCs)) (PP (IN from) (NP (NP (NN CF) (NNS patients)) (CC and) (NP (NNS controls))))) (VP (VBP show) (NP (NP (JJ similar) (NNS increases)) (PP (IN in) (NP (NP (NN caspase-1) (NN activity)) (PP (IN upon) (NP (NN inflammasome) (NN activation)))))))) (. .)))
(S1 (S (S (NP (NP (NNS PBMCs)) (PP (IN from) (NP (NP (NP (NN CF) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 6)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 6)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN primed) (PP (IN with) (NP (NP (NN LPS)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (CD 5) (NNS hours)) (ADJP (JJ prior) (PP (TO to) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NP (NP (NN ATP)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mM)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 1) (NN hour)))) (CC or) (NP (NP (NN Poly-LRB-dA:dT-RRB-)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN microg/ml)) (-RRB- -RRB-))))) (PP (IN for) (NP (CD 3) (NNS hours))))))))))) (. .)))
(S1 (S (S (NP (NNS PBMCs)) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (ADJP (FW P.) (FW aeruginosa)) (NN strain) (NN PAO1))) (PP (IN for) (NP (CD 3) (NNS hours)))))) (. .)))
(S1 (S (S (NP (NP (DT A) (JJ representative) (NN histogram)) (PP (IN of) (NP (DT the) (NN %) (JJ caspase-1-active) (NNS cells)))) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (-LRB- -LRB-) (NN A) (-RRB- -RRB-))) (PP (IN with) (NP (NP (DT the) (JJ averaged) (NNS values)) (VP (VBN shown) (PP (IN in) (NP (-LRB- -LRB-) (NN B) (-RRB- -RRB-))))))))) (. .)))
